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Shotgun mass spectrometryDuring their normal in vivo life cycle erythrocytes (red blood cells, RBCs) undergo biochemical changes lead-
ing to membrane microvesiculation and shedding. RBC microvesiculation also occurs in vitro under condi-
tions of blood bank storage, so microvesicles (MVs) accumulate in the storage (preservation) medium over
storage time. Considerable effort has been put into gaining a mechanistic understanding of the RBC
microvesiculation process, as this is crucial to better understand RBC biology in disease and in health. Addi-
tionally, MVs accumulated in stored RBCs have been implicated in transfusion adverse inﬂammatory reac-
tions, with chloroform extractable compounds, thus lipophilic, known to trigger the effect. However,
because thin layer chromatography resolution of RBC and MV lipids has always enabled one to conclude
high compositional similarities, in depth analysis of MV lipids has not been extensively pursued. Here we
present an orbitrap mass spectrometry (MS) approach to compare the phospholipid composition of RBCs
and MVs from leukoreduced, hypothermically (2–6 °C) stored RBC units. We used shotgun MS analysis and
electrospray ionization (ESI) intra-source separation, and demonstrated high similarity of compositional pro-
ﬁles, except for glycerophosphoserines (PS). Contrasting abundances of PS 38:4 and PS 38:1 characterized
MV and RBC proﬁles and suggested that storage-associated microvesiculation possibly involves shedding of
speciﬁc membrane rafts. This ﬁnding indicates that phospholipidomics could likely contribute to a better un-
derstanding of the RBC microvesiculation process.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Storage lesion, a term now in use for almost half century [1], de-
scribes the physical and chemical changes observed in red blood
cells (RBCs) stored for transfusion, and has been consistently applied
to refer to metabolic depletion, membrane loss of asymmetry and
membrane shedding through microvesiculation [2]. This latter aspect
of the RBC storage lesion, i.e. microvesiculation, has been a meeting
point for a variety of research areas (e.g. biopreservation, aging, dis-
eases, signaling) seeking insight into RBC lipid–protein physiology
[3–5]. As for being ﬁt into a liquid-like structure concept including
long-range and short-range orders dynamically displayed in various
lengths and time scales [6], the RBC membrane is still complex to cur-
rent understanding, especially with reference to themicrovesiculation
process.
In spite of other intrinsic factors [7], spectrin (RBC skeleton lattice
protein) has been implicated in sustaining RBC membrane asymme-
try through selective interactions with glycerophosphoserines (PS), Research and Development,
. Fax: +1 780 702 8621.
rights reserved.[8,9]. Accordingly, structural damage to spectrin (e.g. oxidation), ca-
pable of compromising PS anchoring sites, is postulated to promote
diffusion of PS to the outer membrane [10,11]. Once PS is exposed,
the membrane becomes thrombogenic [12] and pro-inﬂammatory
[13]. Increased PS exposure has been observed in membrane-derived
microvesicles (MVs) from fresh [14,15] and hypothermically-stored
[16] RBC preparations. In the RBC itself, membrane asymmetry is not
signiﬁcantly altered after microvesiculation [17], even during hypo-
thermic storage [15]. For this reason, RBC-derivedMVs have been pos-
tulated to be involved in transfusion related adverse reactions [18,19].
Moreover, accumulation of lipids with platelet activating factor
(PAF)-like activity in the preservation medium (citrate–phosphate–
dextrose–adenine) of whole blood and packed RBC units have been
reported [19,20] and postulated to be relevant to transfusion related
acute lung injury (TRALI) [21]. Their preliminary identiﬁcation as
lyso-glycerophosphocholines (LPC) [22] has been argued since accu-
mulation of LPCs was shown to be blood plasma dependent [23]
and hence unable to explain the PAF-like activity in the supernatant
of stored, leukoreduced, RBC units [24]. More recently, a few
pro-inﬂammatory oxidation products of arachidonic acid, mainly
5-hydroxyeicosatetraenoic acid (5-HETE), were reported to accumu-
late in the supernatant fraction of leukoreduced RBCs [25]. The
PAF-like activity of leukoreduced RBC supernatants was shown to be
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that the bioactive compounds were linked to membrane MVs [26].
Apart from the contributions cited above, lipid analysis of RBC
MVs has been conducted using lipid group separation on thin layer
chromatography prior to spectrophotometric determinations of
cholesterol-to-phospholipid ratios [27–30], and these studies have
repeatedly demonstrated that RBCs and derived MVs are composi-
tionally similar. Interestingly, RBCs and derived MVs have never
been compared from the perspective of phospholipid species distri-
bution, despite it being acknowledged that membrane protein sorting
[31] occurs during the onset of RBC microvesiculation. From a clinical
point of view, recognizing membrane compositional patterns of
transfusional RBCs and relatedMVs is important for establishingmea-
surable membrane compositional parameters in reference to product
quality that may contribute to assessing preservation strategies
and broadening current understanding of the physical changes
displayed by RBCs during storage. This present study was under-
taken with the aim of comparing the phospholipid composition
of blood bank hypothermically (2–6 °C) stored, leukoreduced,
SAGM (saline–adenine–glucose–manitol) preserved RBCs and de-
rived MVs. A non-targeted phospholipidomics approach was
used, relying on a Fourier transform orbitrap mass spectrometer,
whose level of performance with respect to mass resolution and
accuracy has been tutorially described recently [32]. It was appar-
ent that compositional differences in the membrane distribution of
PSs exist between RBCs and MVs.
2. Materials and methods
2.1. Chemicals
Organic solvents were HPLC grade. Chloroform was purchased
from EMD Chemicals Inc. (Darmstadt, Germany), methanol and
2-propanol purchased from Sigma-Aldrich (St. Louis, MO, USA). Phos-
phate buffered saline (PBS 1×, without calcium and magnesium) was
from Mediatech Inc. (Manassas, VA, USA). Phosphoric acid (H3PO4)
was from EMD Chemicals Inc. and sodium carbonate (Na2CO3) was
from Sigma-Aldrich. Aqueous solutions were prepared with deion-
ized water. Dimyristoylglycerophosphoethanolamine (PE 28:0),
used as an internal standard, was purchased from Avanti Polar Lipids
(Alabaster, AL, USA). Standard ion calibration solutions (Pierce® LTQ)
for electrospray ionization in positive and negative modes were pur-
chased from Thermo Scientiﬁc (Rockford, IL, USA).
2.2. Red blood cell
Whole blood (450 mL±10%) was collected from healthy vol-
unteer donors into polyvinyl chloride blood collection packs
containing 70 mL±10% citrate–phosphate–dextrose anticoagulant
(Macopharma, Mouvaux, France) at Canadian Blood Services
(Vancouver, BC, Canada). Whole blood units were rapidly placed on
butanediol cooling plates (Fresenius CompoCool) and processed for
RBC extraction within 24 h of post-collection. After separation of buffy
coat (47.5 mL±4%) and plasma (275 mL±7%) by centrifugation
at 22 °C (3500 rpm, HBB-6 rotor, Sorval RC3BP, ThermoScientiﬁc),
RBCs were suspended in 110 mL of SAGM additive solution and
leukoreduced by ﬁltration at room temperature. Resulting RBC units
(284±5%) were hypothermically stored (2–6 °C) under standard
blood bank conditions. Six RBC units stored for 53±4 days wereFig. 1. Representative shotgun (1 min/run) mass scan (m/z 600–900) proﬁles of red blood ce
using electrospray ionization (ESI) in positive (ESI+) and negative (ESI−) modes. Dimyristo
tion as an internal reference. Mass resolution is given as R, and accuracy values in ppm. C
whereas serine and inositol-containing phospholipids were detected as negatively charge
modes.analyzed, as outdated units were expected to be enriched in
MVs. Donors were females and males of diversiﬁed serotypes.2.3. Separation of RBCs and microvesicles
SAGM preserved RBCs (average hematocrit=64%±2.9%) were
centrifuged at 3200 ×g for 30 min, at 4 °C, in 50 mL polypropylene
conical tubes. Supernatants resulting from this ﬁrst step centrifuga-
tion were transferred to new 50 mL polypropylene conical tubes
and centrifuged (3200 ×g, 30 min, 4 °C) for acellular debris
clean-up. Cleaned-up supernatants were subjected to ultracentrifuga-
tion (50,000 ×g, 60 min, 4 °C; rotor JA-25.50, Beckman Coulter) and
MVs obtained as bright red pellets. These were collected in phosphate
buffered saline (PBS 1×), volume normalized to 0.75 mL, and stored
at −20 °C until lipid extraction for analysis. RBCs resulting from the
ﬁrst step centrifugation were sampled (500 μL) and washed (2×,
2500 ×g, 5 min, 4 °C) with 500 μL cold (4 °C) PBS 1× and then stored
at −20 °C until lipid extraction for analysis.2.4. Lipid extraction
Sample aliquots of PBS-washed RBCs (100 μL) and PBS-suspended
MVs (100 μL) were transferred to 10 mL borosilicate disposable glass
tubes (100×10 mm i.d.) containing 2 μg (20 μL of 0.1 mg/mL) of PE
28:0 (in CHCl3–MeOH, 2:1, v/v) as an internal reference. Samples
were acidiﬁed with 1 mL 5 mM aqueous H3PO4, and vortex-mixed
(30 s) with 1 mL 2-propanol and 3 mL CHCl3. Then, 0.5 mL 25 mM
aqueous Na2CO3 was added and vortex-mixed (30 s), bringing the
ﬁnal extraction medium to pH 7 (pH indicator strips, EMD Chemicals,
Gibbstown, USA). Tubes were centrifuged (2200 ×g, 10 min, 4 °C)
and resulting bottom phases transferred to 4 mL borosilicate glass
vials (45×12 mm i.d.), which were heated (55 °C) for solvent evapo-
ration under gentle nitrogen stream. Solvent-free extracts were
redissolved in 0.3 mLMeOH–CHCl3–20 mM aqueous ammonium ace-
tate (4:1:1, v/v/v) and refrigerated (−20 °C) until analysis.2.5. Shotgun mass spectrometry
Lipid extracts were infused (3 μL/min) into an Ion Max electron
spray ionization (ESI) source mounted on a LTQ Orbitrap XL (Thermo
Scientiﬁc, San Jose, CA, USA). The orbitrap mass analyzer was calibrat-
ed with standard ion calibration solutions (Pierce LTQ, Thermo Scien-
tiﬁc) and compound dependent instrument parameters were tuned
using a 10 μg/mL PE 28:0 solution (MeOH–CHCl3–20 mM aqueous
ammonium acetate, 4:1:1, v/v/v) either for electrospray positive
(ESI+) or electrospray negative (ESI−) ionization modes. Acquisi-
tion parameters were as follows: source temperature (ESI+ and
ESI−)=350 °C, source voltage (ESI+ and ESI−)=3.5 kV, capillary
voltage=13 V (ESI+) and −14 V (ESI−), tube lens voltage=90 V
(ESI+) and −130 V (ESI−), and sheath gas ﬂow=20 (arbitrary
units, ESI+ and ESI−). Full scan acquisitions lasting 1 min/sample
were performed in them/z 500–900 range, using a nominal resolving
power of 60,000 FWHM (full-width at half-maximum peak height at
m/z 400). Product ion scan acquisitions in the range of m/z 50–850
were performed for fatty acid analysis in ESI− by applying a collision
energy of 35 (arbitrary units) for higher energy collision dissociation
(HCD). Product ions were recorded for 1 min/sample.lls (RBC) and associated microvesicle (MV) lipids acquired with an orbitrap instrument
yl-glycerophosphoethanolamine (PE 28:0) was spiked into samples before lipid extrac-
holine-containing phospholipids were detected as positively charged species in ESI+
d in ESI−. Ethanolamine-containing phospholipids were detected in both ionization
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Recorded data were analyzed using Xcalibur 2.1 software (Thermo
Scientiﬁc). Fourier transform full scan mass spectra resulting from
0.1 to 1.0 min acquisitions were analyzed for the presence of com-
pounds containing at maximum 50 carbon (12C), 100 hydrogen
(1H), 15 oxygen (16O), 2 nitrogen (14N) and 2 phosphorous (31P)
atoms. The spectra, converted into lists relating m/z, peak intensity,
and the most accurate mass-compatible elemental composition,
were aligned using Excel tools. The peak intensities were normalized
to the internal standard and the characterized phospholipids were
assessed for relative abundance.
2.7. Statistical analysis
All data were expressed as mean±standard deviation (SD) from 6
independent RBC units and were subjected to two-tailed, unequal
variance Student's test. A probability (p) valueb0.05 was considered
statistically signiﬁcant.
3. Results
3.1. Untargeted phospholipidome proﬁles
Just prior to MV pelleting, the MV containing RBC supernatants
were assessed for particle size using dynamic light scattering. Mixed
populations of particle sizes were observed but none exceeding
280 nm in diameter (results not shown). Acquisition of ESI+ and
ESI− full scan (m/z 500–900) mass spectrometry (MS) lipidome pro-
ﬁles of outdated RBCs and associated MVs was straightforward. Rep-
resentative samples of the spectra obtained are shown in Fig. 1.
Choline-containing phospholipids [glycerophosphocholines (PC) and
sphyngomyelins (SM)] were analyzed as positively charged in ESI+,
while serine-containing species (PS) were analyzed as negatively
charged in ESI−. Ethanolamine-containing phospholipids were
detected in either ionization mode (Fig. 1, inserts: PE 28:0), although
analyzed with superior sensitivity in ESI−. As indicated by the IS
peak (Fig. 1, inserts), achieved resolution (R, given as full width at
half peak maximum) and mass accuracy (given in parts per million,
ppm) enabled the expected elemental composition assignments
(C33H67O8NP [M+H]+; C33H65O8NP [M−H]−) for the correctFig. 2. Relative distribution of FTMS signal intensity per elemental composition categ
microvesicles (MV). Chemical formula in horizontal axis refers to charged molecule ions
stand for an odd number, while subscripts “w” and “z” stand for an even number.
glycerophosphocholine sn-1 ethers, (PC) glycerophosphocholine, (SM) sphingomyelin, (P
(PE-ox) glycerophosphoethanolamine oxidized, (PS) glycerophosphoserine, and (PI) glycidentiﬁcation of PE 28:0 in both ionization modes (mean accura-
cy±SD, n=12, ESI+: −1.0±0.4 ppm; ESI−: 2.2±0.5 ppm).
Throughout the lipidome proﬁles, R ranged within 50,000–55,000
and accuracy within limits of ±3.0 ppm.
3.2. Main elemental composition categories
Acquired m/z peaks were grouped in elemental composition cate-
gories classiﬁed by the number of N, O and P atoms present in the
most accurate molecular formula calculated (XCalibur software).
They were then assessed for relative abundance (%) in the context of
signal intensity. The following combinations of N, O and Pwere consis-
tently observed: NO7P, NO8P, N2O6P, NO9P, NO10P, O13P; and these
were correlated to the following phospholipid head groups: in ESI+,
NO7P = PC sn-1 ethers (PC-o), NO8P = PC, and N2O6P = SM; in
ESI−, NO7P = PE plasmalogens (PE-p), NO8P = PE, NO9P = oxidized
PE (PEox), NO10P = PS, and O13P = glycerophosphatidylinositol (PI).
These are illustrated in Fig. 2, with chemical formula assigned on the
horizontal axis referring to charged molecular ions {[M+H]+,
[M+H]−} in which carbon (C) and hydrogen (H) atoms subscripts
“x” and “y” stand for odd numbers respectively, and “w” and “z” sub-
scripts stand for even numbers, respectively. Within assigned catego-
ries, C and H numbers varied according to the length and degree
of unsaturation (number of double bonds) of the phospholipid-
associated acyl chains.
3.3. ESI+ acquired phospholipids
Overall, PCs (CwHyNO8P, Fig. 2) and PC-os (CwHyNO7P, Fig. 2) were
assigned with−2.2±2.0 ppm and−3.4±0.4 ppm accuracy, respec-
tively. Their relative compositional proﬁles in MVs and RBCs are
presented in Figs. 3 and 4. PC and PC-o species ranging from 32 to
40 total acyl chain C atoms bearing up to 8 double bonds were deter-
mined. PCs were similarly distributed in RBCs and MVs (Fig. 3). The
species PC 34:1 (m/z 760.6) and PC 34:2 (m/z 758.6) were relatively
predominant, and individually accounted for 20% of total choline-
containing phospholipids in RBCs and MVs. PC-o species of 34 total
acyl chain C atoms were also predominant in the PC-o proﬁle of
MVs and RBCs (Fig. 4). The distribution of a few PC-o species (PC-o
36:2, PC-o 38:2, PC-o 40:3) towards a higher abundance in RBCs rel-
ative to MVs can be observed in Fig. 4, although this is hard toory subsequently assigned to a phospholipid group in red blood cells (RBC) and
{[M+H]+, [M+H]−} in which carbon (C) and hydrogen (H) subscripts “x” and “y”
Correspondingly assigned phospholipid groups are shown in parenthesis; (PC-o)
E-p) glycerophosphoethanolamine plasmalogens, (PE) glycerophosphoethanolamine,
erophosphoinositol. Values are mean+SD from 6 different RBC units.
Fig. 3. Glycerophosphocholine (PC) species in red blood cells (RBC) and related microvesicles (MV) plotted by their relative abundance within the PC group. Values are mean+SD
(n=6 different RBC units).
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positional context (PC-os=1% of PCs, Fig. 2).
SMs (CxHzN2O6P) were assigned with an error of −1.1±0.8 ppm,
assuming all the species were of the dihydroxy C18:1 sphingoid base
type, which are known to predominate in human blood [33]. SMs in
the range of 14–24 acyl chain C atoms were determined (Fig. 5),
with the major species SM 16:0 (m/z 703.6), SM 24:0 (m/z 815.7)
and SM 24:1 (m/z 813.7) accounting altogether for 20% of the total
signal intensity attributed to choline-containing phospholipids in
RBCs and MVs.
3.4. ESI− acquired phospholipids
PE (CxHyNO8P, Fig. 2) and PE-p (CxHyNO7P, Fig. 2) species were
assigned with accuracies of −1.5±0.5 ppm and −2.0±0.6 ppm, re-
spectively. In contrast to the ether counterpart PC-os, PE-ps accounted
for 30% of total ESI− assigned phospholipids in either RBCs or MVs,
and were as abundant as 46% PEs in RBCs and as much as 80% of PEs
in MVs (Fig. 2). The observed disproportions resulted from the differ-
ences in signal intensity displayed by total PEs in the ESI− proﬁles ofFig. 4. Glycerophosphocholine sn-1 ether (PC-o) species in red blood cells (RBC) and micr
mean+SD (n=6 different RBC units).MVs and RBCs (Fig. 2). Illustrated in Fig. 6 is the relative distribution
of the assigned PE species in MVs and RBCs, which ranged from 34 to
40 total acyl chain C atoms and were determined containing up to
total 6 unsaturations (double bonds). PE 34:1 (m/z 716.5) predom-
inated over other PE species both in RBCs and MVs (Fig. 6), although
relatively, these were even more abundant in RBCs (35% of PEs) than
in MVs (25% of PEs). PE 34:1 accounted greatly for the observed dif-
ferences in total RBC and MV PE intensities reported in Fig. 2. Apart
from this observation, polyunsaturated (>2 double bonds) PEs
were, in general, slightly enriched in MVs relative to the RBCs
(Fig. 6). Interestingly, among very low abundant species, which
contributed to a maximum of 0.2% of the total signal intensity
displayed by the PE group proﬁle, odd-acyl chain PEs (PE 35:1, m/z
730.5; PE 35:2, m/z 728.5; PE 37:5, m/z 750.5; PE 37:6, m/z 748.5,
Fig. 6— inserts) weremostly enriched in RBCs. Determined PE-p spe-
cies are presented in Fig. 7. These ranged from 36 to 40 total acyl
chain C atoms, were predominantly polyunsaturated and similarly
distributed in RBCs and MVs.
Compounds grouped in the elemental composition category
CxHyNO9P (Fig. 2) were assigned with an error of −2.8±0.4 ppmovesicles (MV) plotted by their relative abundance within the PC-o group. Values are
Fig. 5. Sphingomyelin (SM) species in red blood cells (RBC) and microvesicles (MV) plotted by their relative abundance within the SM group. Values are mean+SD (n=6 different
RBC units).
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2% (1.7% in MVs, 1.9% in RBCs) of the assigned ESI− acquired phos-
pholipids (Fig. 2) and varied in the range of 34–44 total acyl chain
C atoms (Fig. 8). Lower molecular weight PE-ox ranging from 34 to
36 total acyl chain C atoms [PE-ox 34:0 (m/z 732.5), PE-ox 34:1 (m/z
730.5), PE-ox 36:1 (m/z 758.5)] were enriched in the RBCs whereas
PE-ox of higher molecular weight (>42 total acyl chain Cs) were
enriched in the MVs.
PSs (CwHyNO10P, Fig. 2) ranging from 36 to 44 total acyl chain C
atoms (Fig. 9) were assigned with an error of 1.7±0.7 ppm. In MVs,
23±5.0% of the total assigned ESI− signal intensity was due to PSs,
whereas in RBCs the same assigned PSs accounted for only 3±1.2%
of the attributed ESI− signal intensity (Fig. 2). As shown in Fig. 9,
the compositional proﬁle of MV PSs is characterized by the predomi-
nance of PS 38:4 (m/z 810.5) over PS 40:6 (m/z 834.5), PS 40:5 (m/z
836.5) and PS 40:4 (m/z 838.5), whereas in the RBCs, PS 38:1 (m/z
816.5) predominated over PS 38:4, PS 40:1 (m/z 844.6) and PS 40:0Fig. 6. Glycerophosphoethanolamine (PE) species in red blood cells (RBC) and microvesicle
(n=6 different RBC units).(m/z 846.6). Differences in the relative abundance of PS 38:4, PS
38:1 and PS 40:6 in RBCs and MVs were statistically signiﬁcant
(pb0.001). Insight into the acyl chain composition of the predomi-
nant PSs in MVs was gained through analysis of their product ions.
As shown in Fig. 10, PS 38:4 contained a stearoyl chain (C18:0; m/z
283) and an eicosatetranoyl (arachidonoyl) chain (C20:4; m/z 303)
respectively linked to the sn-1 (indicative fragment ions: m/z 419,
437) and sn-2 (indicative fragment ions: m/z 439) positions of the
PS backbone. Similarly, Fig. 11 shows that PS 40:6 was predominantly
formed by a stearoyl chain (m/z 283, C18:0) at position sn-1 (m/z 419,
437) and a docosahexanoyl chain (m/z 3237, C22:6) at position sn-2
(m/z 463) of the PS backbone. For the remaining MV PSs (Fig. 9),
whichwere present in relatively low abundance, the product ion spectra
obtained through shotgun MS were not as clear, and thus inconclusive.
PIs (CxHzO13P, Fig. 2) wereminor sample constituents accounting for
only 1±0.6% of assigned ESI− acquired phospholipids in MVs and for
less than 0.1% (0.02±0.01%) of assigned ESI− acquired phospholipidss (MV) plotted by their relative abundance within the PE group. Values are mean+SD
Fig. 7. Glycerophosphoethanolamine plasmalogen (PE-p) species in red blood cells (RBC) and related microvesicles (MV) plotted by their relative abundance within the PE-p group.
Values are mean+SD (n=6 different RBC units).
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whichwas the only PI species detected in the RBCs and the predominant
one (0.9%) in the MVs, in which trace amounts (0.02–0.05% of ESI−
assigned species) of PI 38:5 (m/z 883.5), PI 36:2 (m/z 861.5) and PI
36:3 (m/z 859.5) were also determined. Since PIs are polyhydroxylated
and expectedly lowabundant phospholipids, these results suggest differ-
ences in extraction efﬁciency.4. Discussion
The analysis was performed relying on the hypothesis that RBC-
derived MVs constituted the predominant population of MVs in the
hypothermically stored RBC units used in this study. The phospho-
lipidomics approach used in this paper has not been previously applied
to characterize stored RBCs produced under blood bank conditions. A
similar analytical procedure was applied to the characterization of RBCs
collected and treated outside the context of component processing and
blood bank storage [34]. The phospholipid proﬁle described by LeidlFig. 8. Oxidized glycerophosphoethanolamine (PE-ox) species in red blood cells (RBC) and r
Values are mean+SD (n=6 different RBC units).et al. [34] is representative of a fresh (drawn>washed>analyzed) RBC
preparation and is referred to in the following text as “fresh RBCs”.
Non-targeted ESI-FTMS phospholipidome proﬁles of leukoreduced,
SAGM preserved, hypothermically stored (53±4 days) RBCs and asso-
ciated MVs were compared in order to shed light onto the membrane
compositional features of outdated blood bank-stored RBCs. On the
basis of intrasource separation (Fig. 1), high mass resolution and high
accuracy, we observed great similarity between RBCs and MVs in
terms of their relative compositional abundance of PCs and SMs
(Figs. 2, 3, 5). Observed PC and SM proﬁles closely resembled the PC
and SM proﬁles previously reported for fresh RBCs [34]. The
microvesiculation phenomenon apparently did not disturb PC and SM
RBC membrane organization. Regarding PC-os (Fig. 4), proﬁle differ-
ences were observed for the distribution of PC o-36:2, PC o-38:2, and
PC o-40:3, which were enriched in RBCs. Further studies are required
to better understand this ﬁnding. An interesting aspect of PC-os is
the basic structure relationship they hold with PAF (1-O-palmityl-2-
acetyl-glycerophosphocholine), which might explain their relative
downregulation in the biosystem.Nevertheless, presently characterizedelated microvesicles (MV) plotted by their relative abundance within the PE-ox group.
Fig. 9. Glycerophosphoserine (PS) species in red blood cells (RBC) and related microvesicles (MV) plotted by their relative abundance within the PS group. Values are mean+SD
(n=6 different RBC units). *pb0.05, **pb0.01, ***pb0.001.
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far as their sn-2 position remains occupied by a long chain acyl group
[35]. Apart from the assigned highly unsaturated PC-o species (PC
o-36:7, PC o-36:8, PC o-38:8), remaining PC-os have been previously
described in fresh RBCs [34].
The PE proﬁle of stored RBCs (Fig. 6) resembles the PE proﬁle of
fresh RBC [34], although PE 34:1 is relatively enriched in the stored
cells. PE 34:1 is also abundant in the MVs, though these are relatively
enriched in polyunsaturated PEs. Conjugated double bonds imprint
antioxidant capacity and also account for the rheological properties
of the erythrocyte membrane [36]. The highly polyunsaturated PE-ps
(Fig. 7) were also relatively enriched in the MVs, as in the group-
phospholipidome proﬁles (Fig. 2), PE-ps presented a close to unitFig. 10. Product ion spectrum of PS 38:4 presenting evidence for the presence of a sn-abundance relationship with PEs in the MVs, whereas in RBCs this
ratio dropped to half. PE-ps have been largely acknowledged for
their biologically relevant antioxidant capacity [37]. On the other
hand, when polyunsaturated phospholipids exert an antioxidant func-
tion, they result in the formation of oxidized polyunsaturated phos-
pholipids: a potential source of pro-inﬂammatory lipid mediators
[38,39]. PE-p 38:4, likely a combination of p-18:0/20:4 acyl groups,
and therefore a source of arachidonic acid, was the most abundant
PE-p in the stored RBCs and MVs, as well as in previously analyzed
fresh RBCs [34]. The majority of assigned PE-oxs were polyunsaturat-
ed (Fig. 8) and also enriched in the MVs. Their elemental composition
(CxHyNO9P) suggests twomost likely interpretations: their correspon-
dence to PE-p peroxides and/or to PE epoxides. Co-existence of both1 stearoyl (C18:0) and a sn-2 eicosatetranoyl (C20:4, arachidonoyl) acyl moieties.
Fig. 11. Product ion spectrum of PS 40:6 presenting evidence for the presence of a sn-1 stearoyl (C18:0) and a sn-2 docosahexanoyl (C22:6) acyl moieties.
325B. Bicalho et al. / Biochimica et Biophysica Acta 1828 (2013) 317–326possibilities is actually reasonable in view of the acyl chain length and
degree of unsaturation of the PE-oxs (Fig. 8). Their relative abun-
dances, however, did not sufﬁce to yielding conclusive product ion
spectra in the shotgunMS approach. Further workwill address comple-
mentary structural information. That oxidized phospholipids were
observed was not surprising, since oxidative stress has been consis-
tently observed to increase with storage duration in hypothermically
(2–6 °C) stored RBCs [40].
Themost intriguing outcome of our analysis is probably the observed
differences in PS distribution in the stored RBCs andMVs (Fig. 9). The PS
proﬁle observed forMVs, in which the arachidonoyl-PS (PS 38:4, Fig. 10)
predominates, is in perfect agreement with the PS proﬁle of fresh RBCs
[34]; in contrast the PS proﬁle observed for stored RBCs, in which PS
38:1 predominates, disagrees with the proﬁle of fresh RBCs, as PS 38:1
was found to be among the least abundant PS species in the latter [34].
Microvesiculation has interfered in the RBC PS composition to an extent
not observed for the other phospholipids analyzed. Our results indicate
an apparent preferential membrane shedding of polyunsaturated PSs
to RBC MVs. On that basis we suggest that polyunsaturated PSs would
be likely enriched in membrane rafts rather than evenly scattered in
the inner layer. The involvement of lipid rafts in RBC microvesiculation
has already been considered [41] since stomatin has been shown to accu-
mulate in RBC MVs during hypothermic storage [12]. Therefore,
phospholipidomics could likely contribute to a better understanding of
the RBC microvesiculation process. Studies on RBC biopreservation
could also beneﬁt from phospholipidomics since in this ﬁeld close con-
trol of the RBC membrane composition is required.5. Conclusion
This paper reported compositional differences between stored
RBCs and associated MVs in terms of PSs, which suggested the onset
of lipid bilayer compositional remodeling during microvesiculation,
possibly in consequence of shedding membrane rafts enriched in
polyunsaturated PSs. It was also shown that in stored, outdatedRBCs the PS proﬁle no longer resembled the PS proﬁle of fresh RBCs.
In general, MVs were shown to be relatively enriched in polyunsatu-
rated phospholipids. Future work will address i) whether observed PS
proﬁles are generalizable, ii) how they change during the time course
of hypothermic storage and iii) how they are inﬂuenced by different
manufacturing methods used in modern blood banks.
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